表纸
市场调查报告书

代谢性疾病用医药品的全球市场:抗糖尿病药物·抗甲状腺药·其他医药品 (副甲状腺机能亢进症·下垂体功能降低症·肾上腺功能降低症)

Metabolic Disorders Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

出版商 The Business Research Company 商品编码 531331
出版日期 内容资讯 英文
商品交期: 2-3个工作天内
价格
代谢性疾病用医药品的全球市场:抗糖尿病药物·抗甲状腺药·其他医药品 (副甲状腺机能亢进症·下垂体功能降低症·肾上腺功能降低症) Metabolic Disorders Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
出版日期: 2020年05月19日内容资讯: 英文
简介

本报告提供全球代谢性疾病用医药品的市场调查,提供市场定义和概要,市场的各种影响因素分析,各药物部门·各地各国趋势与市场规模的变化与预测,并汇整与宏觀经济因素·医疗保健市场全体·各种产业指标的比较,竞争环境,企业简介等资料。

第1章 市场特征

第2章 市场规模·成长率

  • 市场成长:迄今的过程
    • 成长推进因素
    • 阻碍成长要素
  • 市场成长:预测
    • 成长推进因素
    • 阻碍成长要素

第3章 大环境分析

第4章 客户资讯

第5章 代谢性疾病用医药品市场分析:各种类

  • 全球市场的实际成果:各种类
    • 抗糖尿病药物
    • 抗甲状腺药
    • 其他
      • 副甲状腺机能亢进症
      • 下垂体功能降低症
      • 肾上腺功能降低症
  • 全球市场的变化与预测:各种类
  • 市场趋势·策略

第6章 代谢性疾病用医药品市场分析:各地各国分析

  • 全球市场的实际成果:各地区
  • 全球市场的变化与预测:各地区
  • 市场实际成果:各国
  • 市场变化与预测:各国
  • 全球医药品市场实际成果:部门·各地区
  • 全球医药品市场实际成果:部门·各国

第7章 宏觀经济因素与市场比较

  • 市场规模的占 GDP的百分比
  • 平均每个人的平均支出额

第8章 宏觀经济因素与市场比较:各国

  • 市场规模的占 GDP的百分比:各国
  • 平均每个人的平均支出额:各国

第9章 产业指标与市场比较

  • 全球药剂师数:各国
  • 市场收益 vs 药剂师数:各国
  • 全球医药品公司数:各国
  • 市场收益 vs 医药品公司数:各国
  • 全球对R&D/产品开发的平均支出额:各国
  • 市场收益 vs 对R&D/产品开发的平均支出额:各国
  • 全球非专利&品牌销售额的比例:各国
  • 市场收益 vs 非专利&品牌销售额的比例:各国
  • 高血压的患病人数:各国
  • 全球一般开业医生数:各国
  • 市场收益 vs 一般开业医生数:各国

第10章 亚太地区市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类
  • 各国分析
  • 中国
  • 印度
  • 日本
  • 澳洲

第11章 西欧市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类
  • 各国分析
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙

第12章 东欧市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类
  • 各国分析
  • 俄罗斯

第13章 北美市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类
  • 各国分析
  • 美国

第14章 南美市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类
  • 各国分析
  • 巴西

第15章 中东市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类

第16章 非洲市场

  • 市场概要
  • 市场过去的转变
  • 市场预测
  • 市场实际成果:各种类

第17章 竞争环境

  • 企业简介
  • Novo Nordisk
  • Sanofi
  • Merck & Co.
  • Eli Lilly
  • Astrazeneca PLC

第18章 主要M&A:代谢性疾病用医药品市场

第19章 市场背景:医药品市场

第20章 医药品产业的Financial Margins

第21章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

‘Metabolic Disorders Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global metabolic disorders drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the metabolic disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Metabolic Disorders Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider metabolic disorders drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The metabolic disorders drugs market section of the report gives context. It compares the metabolic disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, metabolic disorders drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Anti Diabetics drugs; Anti-Thyroid drugs; Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Sanofi S.A; Novo Nordisk A/S; AstraZeneca Plc; Johnson & Johnson; Merck & Co

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, metabolic disorders drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Metabolic Disorders Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Metabolic Disorders Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Metabolic Disorders Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Metabolic Disorders Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Metabolic Disorders Drugs Market Trends And Strategies

8. Metabolic Disorders Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Metabolic Disorders Drugs Market Regional Analysis

  • 9.1. Global Metabolic Disorders Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

10. Metabolic Disorders Drugs Market Segmentation

  • 10.1. Global Metabolic Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Anti Diabetics drugs

Anti-Thyroid drugs

Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

  • 10.2. Global Metabolic Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Metabolic Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Metabolic Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Metabolic Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Metabolic Disorders Drugs Market Metrics

  • 11.1. Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Metabolic Disorders Drugs Market

  • 12.1. Asia-Pacific Metabolic Disorders Drugs Market Overview
  • 12.2. Asia-Pacific, Metabolic Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Metabolic Disorders Drugs Market Metrics
    • 12.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • 12.6. Asia-Pacific Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Metabolic Disorders Drugs Market: Country Analysis
    • 12.7.1. China Metabolic Disorders Drugs Market
      • 12.7.1.1. China Metabolic Disorders Drugs Market Overview
      • 12.7.1.2. China Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Metabolic Disorders Drugs Market
      • 12.7.2.1. Australia Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Metabolic Disorders Drugs Market
      • 12.7.3.1. Hong Kong Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Metabolic Disorders Drugs Market
      • 12.7.4.1. India Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Metabolic Disorders Drugs Market
      • 12.7.5.1. Indonesia Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Metabolic Disorders Drugs Market
      • 12.7.6.1. Japan Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Metabolic Disorders Drugs Market
      • 12.7.7.1. Malaysia Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Metabolic Disorders Drugs Market
      • 12.7.8.1. New Zealand Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Metabolic Disorders Drugs Market
      • 12.7.9.1. Philippines Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Metabolic Disorders Drugs Market
      • 12.7.10.1. Singapore Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Metabolic Disorders Drugs Market
      • 12.7.11.1. South Korea Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Metabolic Disorders Drugs Market
      • 12.7.12.1. Thailand Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Metabolic Disorders Drugs Market
      • 12.7.13.1. Vietnam Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Metabolic Disorders Drugs Market

  • 13.1. Western Europe Metabolic Disorders Drugs Market Overview
  • 13.2. Western Europe, Metabolic Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Metabolic Disorders Drugs Market Metrics
    • 13.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2023, Western Europe Countries
  • 13.6. Western Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Metabolic Disorders Drugs Market: Country Analysis
    • 13.7.1. Austria Metabolic Disorders Drugs Market
      • 13.7.1.1. Austria Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Metabolic Disorders Drugs Market
      • 13.7.2.1. Belgium Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Metabolic Disorders Drugs Market
      • 13.7.3.1. Denmark Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Metabolic Disorders Drugs Market
      • 13.7.4.1. Finland Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Metabolic Disorders Drugs Market
      • 13.7.5.1. France Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Metabolic Disorders Drugs Market
      • 13.7.6.1. Germany Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Metabolic Disorders Drugs Market
      • 13.7.7.1. Ireland Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Metabolic Disorders Drugs Market
      • 13.7.8.1. Italy Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Metabolic Disorders Drugs Market
      • 13.7.9.1. Netherlands Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Metabolic Disorders Drugs Market
      • 13.7.10.1. Norway Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Metabolic Disorders Drugs Market
      • 13.7.11.1. Portugal Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Metabolic Disorders Drugs Market
      • 13.7.12.1. Spain Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Metabolic Disorders Drugs Market
      • 13.7.13.1. Sweden Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Metabolic Disorders Drugs Market
      • 13.7.14.1. Switzerland Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Metabolic Disorders Drugs Market
      • 13.7.15.1. UK Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Metabolic Disorders Drugs Market

  • 14.1. Eastern Europe Metabolic Disorders Drugs Market Overview
  • 14.2. Eastern Europe, Metabolic Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Metabolic Disorders Drugs Market Metrics
    • 14.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • 14.6. Eastern Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Metabolic Disorders Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Metabolic Disorders Drugs Market,
      • 14.7.1.1. Czech Republic Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Metabolic Disorders Drugs Market
      • 14.7.2.1. Poland Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Metabolic Disorders Drugs Market
      • 14.7.3.1. Romania Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Metabolic Disorders Drugs Market
      • 14.7.4.1. Russia Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Metabolic Disorders Drugs Market

  • 15.1. North America Metabolic Disorders Drugs Market Overview
  • 15.2. North America, Metabolic Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Metabolic Disorders Drugs Market Metrics
    • 15.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2023, North America Countries
  • 15.6. North America Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Metabolic Disorders Drugs Market: Country Analysis
    • 15.7.1. Canada Metabolic Disorders Drugs Market
      • 15.7.1.1. Canada Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Metabolic Disorders Drugs Market
      • 15.7.2.1. Mexico Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Metabolic Disorders Drugs Market
      • 15.7.3.1. USA Metabolic Disorders Drugs Market Overview
      • 15.7.3.2. USA Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Metabolic Disorders Drugs Market

  • 16.1. South America Metabolic Disorders Drugs Market Overview
  • 16.2. South America, Metabolic Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Metabolic Disorders Drugs Market Metrics
    • 16.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2023, South America Countries
  • 16.6. South America Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Metabolic Disorders Drugs Market: Country Analysis
    • 16.7.1. Argentina Metabolic Disorders Drugs Market
      • 16.7.1.1. Argentina Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Metabolic Disorders Drugs Market
      • 16.7.1.1. Brazil Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Metabolic Disorders Drugs Market
      • 16.7.3.1. Chile Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Metabolic Disorders Drugs Market
      • 16.7.4.1. Colombia Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Metabolic Disorders Drugs Market
      • 16.7.5.1. Peru Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Metabolic Disorders Drugs Market
      • 16.7.6.1. Venezuela Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Metabolic Disorders Drugs Market

  • 17.1. Middle East Metabolic Disorders Drugs Market Overview
  • 17.2. Middle East, Metabolic Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Metabolic Disorders Drugs Market Metrics
    • 17.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2023, Middle East Countries
  • 17.6. Middle East Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Metabolic Disorders Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Metabolic Disorders Drugs Market
      • 17.7.1.1. Saudi Arabia Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Metabolic Disorders Drugs Market
      • 17.7.2.1. Israel Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Metabolic Disorders Drugs Market
      • 17.7.3.1. Turkey Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Metabolic Disorders Drugs Market
      • 17.7.4.1. UAE Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Metabolic Disorders Drugs Market

  • 18.1. Africa Metabolic Disorders Drugs Market Overview
  • 18.2. Africa, Metabolic Disorders Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Metabolic Disorders Drugs Market Metrics
    • 18.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2023, Africa Countries
  • 18.6. Africa Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Metabolic Disorders Drugs Market: Country Analysis
    • 18.7.1. Egypt Metabolic Disorders Drugs Market
      • 18.7.1.1. Egypt Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Metabolic Disorders Drugs Market
      • 18.7.2.1. Nigeria Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Metabolic Disorders Drugs Market
      • 18.7.3.1. South Africa Metabolic Disorders Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Metabolic Disorders Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Sanofi S.A
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. Novo Nordisk A/S
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. AstraZeneca Plc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Johnson & Johnson
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Merck & Co
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Metabolic Disorders Drugs Market In 2023- Growth Countries
  • 22.2. Global Metabolic Disorders Drugs Market In 2023- Growth Segments
  • 22.3. Global Metabolic Disorders Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer